Resources from ESMO Advanced Courses are exclusively for participants and ESMO Members according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Advanced Course on Early Drug Development 2023: Singapore
- Start date
- 24 Feb 2023
- End date
- 25 Feb 2023
- Singapore, Republic of Singapore
- To foster, educate and mentor the next generation of Phase I/Early Drug Development Programmes in Oncology centres from both the established and emerging economies in the Asia-Pacific region.
- To understand the fundamentals of establishing and running a successful Phase I/Early Drug Development Programme: from an in-depth understanding of trial selection to patient coordination, to running a programme, to effectively engaging with sponsors and fellow PIs, to regional and international engagement, and regulatory processes.
- To bridge the gap between the key stakeholders in the drug development process in the Asia-Pacific region: investigators, sponsors (Pharma and Biotech), Contract Research Organization (CRO), regulatory bodies.
Download the preliminary programme
The programme of this event have been accredited with 10 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
- Jayesh Desai, Australia
- Elena Garralda, Spain
- Brigette Ma, Hong Kong